Davidson Trust Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Davidson Trust Company's ABBV Position: Q3 2026 in Review
Davidson Trust Company reduced its AbbVie (ABBV) stake by 13% in Q3 2026, selling an estimated $1.09M and leaving 29,634 shares worth $7.75M. The position accounts for 3.06% of the portfolio, ranked #3.
Davidson Trust Company first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. The position peaked at $8.95M in Q3 2025. 4,246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Davidson Trust Company held 29,634 shares of AbbVie worth $7.75M as of Q3 2026.
- Davidson Trust Company sold 4,252 AbbVie shares in Q3 2026, an estimated $1.09M.
- AbbVie made up 3.06% of Davidson Trust Company's portfolio in Q3 2026, its #3 holding.
- Davidson Trust Company first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
- Davidson Trust Company's AbbVie position peaked at $8.95M in Q3 2025.
- 4,246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Davidson Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.